carbamates has been researched along with Arterial Occlusive Diseases in 3 studies
Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mishima, Y | 1 |
| Kamiya, K | 1 |
| Sakaguchi, S | 1 |
| Kusaba, A | 1 |
| Sakuma, A | 1 |
| Fényes, G | 1 |
| Gótzy, G | 1 |
| Fehrentheil, L | 1 |
| Zelikovsky, A | 1 |
| Urca, I | 1 |
| Shaklai, M | 1 |
| de Vries, A | 1 |
2 trials available for carbamates and Arterial Occlusive Diseases
| Article | Year |
|---|---|
A multiclinic double-blind trial of pyridinolcarbamate and inositol niacinate in ischemic ulcer due to chronic arterial occlusion.
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Arterial Occlusive Diseases; Arteriosclerosis; Aspart | 1977 |
A clinical trial with pyridinolcarbamate in the treatment of patients with obstructive diseases of the peripheral arteries.
Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis; Carbamates; Female; Femoral Artery; Gait; Human | 1973 |
1 other study available for carbamates and Arterial Occlusive Diseases
| Article | Year |
|---|---|
The effect of Prodectin (pyridinolcarbamate) treatment of the circulation rate in obliterating arterial diseases of the lower extremities.
Topics: Arterial Occlusive Diseases; Carbamates; Drug Evaluation; Humans; Leg; Pyridinolcarbamate; Regional | 1975 |